Work

A study of neo-adjuvant and adjuvant ofra-vec (VB-111) for treatment of surgically accessible recurrent GBM.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps2075

Authors: Patrick Y. Wen, Andrew J. Brenner, Nicholas A. Butowski, Tamar Rachmilewitz Minei, Dror Harats, Timothy Francis Cloughesy

Institutions: Harvard University, Dana-Farber Brigham Cancer Center, The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, University of California, San Francisco, Vascular Biogenics (Israel), University of California, Los Angeles

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281699844

Cites:

Cited by:

Related to: 10